{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:55:42Z","timestamp":1781337342816,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of the Review<\/jats:title>\n                    <jats:p>The aim of this review is to identify barriers and provide solutions to the implementation of inhaled corticosteroid-formoterol as rescue therapy within schools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>GINA guidelines in 2019 and NAEPP in 2020 recommended inhaled corticosteroids combined with formoterol for a rescue inhaler over the traditional short-acting beta-agonist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The findings discussed in this article describe the barriers to the implementation of inhaled corticosteroids combined with formoterol for a rescue inhaler in school systems. Traditional asthma action plans, school nursing and parental education, and differences in dosing are some barriers identified. This paper provides solutions for the barriers, including updating and individualizing asthma action plans and providing thorough education to all parties on appropriate dosing for ICS-formoterol inhalers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11882-026-01282-5","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:12:13Z","timestamp":1781334733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incorporating New Guidelines into School-Based Asthma Management"],"prefix":"10.1007","volume":"26","author":[{"given":"Jessica Michala","family":"Jindra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Duff","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"20","key":"1282_CR1","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","volume":"378","author":"PM O\u2019Byrne","year":"2018","unstructured":"O\u2019Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, et al. Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma. N Engl J Med. 2018;378(20):1865\u201376. https:\/\/doi.org\/10.1056\/NEJMoa1715274.","journal-title":"N Engl J Med"},{"issue":"4","key":"1282_CR2","doi-asserted-by":"publisher","first-page":"2003051","DOI":"10.1183\/13993003.03051-2020","volume":"57","author":"PM O\u2019Byrne","year":"2021","unstructured":"O\u2019Byrne PM, Reddel HK, Beasley R. The management of mild asthma. Eur Respir J. 2021;57(4):2003051. https:\/\/doi.org\/10.1183\/13993003.03051-2020.","journal-title":"Eur Respir J"},{"issue":"6","key":"1282_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","volume":"146","author":"MM Cloutier","year":"2020","unstructured":"Cloutier MM, Baptist AP, Blake KV, Brooks EG, Bryant-Stephens T, DiMango E, et al. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. J Allergy Clin Immunol. 2020;146(6):1217\u201370. https:\/\/doi.org\/10.1016\/j.jaci.2020.10.003.","journal-title":"J Allergy Clin Immunol"},{"key":"1282_CR4","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.5888\/pcd21.240005","volume":"21","author":"CA Pate","year":"2024","unstructured":"Pate CA, Zahran HS. The Status of Asthma in the United States. Prev Chronic Dis. 2024;21:E53. https:\/\/doi.org\/10.5888\/pcd21.240005.","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"1282_CR5","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.1067\/mai.2002.129705","volume":"110","author":"IM Adcock","year":"2002","unstructured":"Adcock IM, Maneechotesuwan K, Usmani O. Molecular interactions between glucocorticoids and long-acting \u03b22-agonists. Allergy Clin Immunol. 2002;110(6):S261\u20138.","journal-title":"Allergy Clin Immunol"},{"issue":"1","key":"1282_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1465-9921-6-107","volume":"6","author":"S Haney","year":"2005","unstructured":"Haney S, Hancox RJ. Tolerance to bronchodilation during treatment with long-acting beta-agonists, a randomized controlled trial. Respir Res. 2005;6(1):107. https:\/\/doi.org\/10.1186\/1465-9921-6-107.","journal-title":"Respir Res"},{"issue":"4","key":"1282_CR7","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1183\/13993003.01872-2019","volume":"55","author":"BI Nwaru","year":"2020","unstructured":"Nwaru BI, Ekstr\u00f6m M, Hasvold P, Wiklund F, Telg G, Janson C. Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872. https:\/\/doi.org\/10.1183\/13993003.01872-2019.","journal-title":"Eur Respir J"},{"issue":"6","key":"1282_CR8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1111\/all.16538","volume":"80","author":"CL Tsao","year":"2025","unstructured":"Tsao CL, Chan SY, Lee MH, Hsieh TYJ, Phipatanakul W, Ruran HB, et al. Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis. Allergy. 2025;80(6):1629\u201346. https:\/\/doi.org\/10.1111\/all.16538.","journal-title":"Allergy"},{"key":"1282_CR9","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention [Internet] 2019 [cited 2026 March 30]. Available from: https:\/\/www.ginasthma.org"},{"issue":"5","key":"1282_CR10","doi-asserted-by":"publisher","first-page":"CD013518","DOI":"10.1002\/14651858.CD013518.pub2","volume":"5","author":"S CrossinghamI, Turner","year":"2021","unstructured":"CrossinghamI,Turner S, Ramakrishnan S, Fries A, Gowell M, Yasmin F, et al. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev. 2021;5(5):CD013518. . https:\/\/doi.org\/10.1002\/14651858.CD013518.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1282_CR24","unstructured":"Global Initiative for Asthma. GINA 2025\/2026 Strat\u00adegy Reports [Internet]. 2025\/2026 [cited 2026 May 25]. Available from: www.ginasthma.org."},{"issue":"10511","key":"1282_CR11","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/S0140-6736(25)00861-X","volume":"406","author":"L Hatter","year":"2025","unstructured":"Hatter L, Holliday M, Oldfield K, Kearns C, Barry T, Black M, et al. CARE study team. Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial. Lancet. 2025;406(10511):1473\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(25)00861-X.","journal-title":"Lancet"},{"key":"1282_CR12","unstructured":"National Heart, Lung, and Blood Institute. Asthma care quick reference: diagnosing and managing asthma [Internet]. 2012 [cited 2026 March 30]. Available from: https:\/\/www.nhlbi.nih.gov\/resources\/asthma-care-quick-reference-diagnosing-and-managing-asthma"},{"key":"1282_CR13","unstructured":"American Academy of Pediatrics. Asthma Action Plan [Internet]. 2021 [cited 2026 March 30]. Available from: https:\/\/www.nhlbi.nih.gov\/sites\/default\/files\/publications\/Asthma-Action-Plan-2020_rev_508.pdf"},{"key":"1282_CR14","unstructured":"American Academy of Allergy, Asthma, and Immunology. Asthma Action Plan [Internet]. 2025 [cited 2026 March 30]. Available from: https:\/\/www.aaaai.org\/Aaaai\/media\/Media-Library-PDFs\/Conditions%20Treatments\/Asthma\/Asthma-Action-Plan.pdf"},{"key":"1282_CR15","unstructured":"American Lung Association. My asthma action plan for home and school [Internet]. 2025 [cited 2026 March 30]. Available from: https:\/\/www.lung.org\/getmedia\/aa8ce6f5-667e-4726-b4ab-8ac8d5d448e4\/fy22-ala-asthma-action-plan_home_school-with-qr-codes.pdf"},{"key":"1282_CR16","unstructured":"National Asthma Council Australia. Asthma Action Plans [Internet]. 2023 [cited 2026 March 30]. Available from: https:\/\/files.nationalasthma.org.au\/resources\/NAC-Asthma-Action-Plan-2023-FILLABLE-HD.pdf"},{"key":"1282_CR17","unstructured":"Virginia Department of Health. Virginia Pediatric Asthma Action Plan [Internet]. 2025 [cited 2026 March 30]. Available from: https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/58\/2016\/12\/Asthma-Action-Plan-2019.pdf"},{"key":"1282_CR25","unstructured":"Asthma and Allergy Foundation of America. Asthma Quick-Relief Medicines in Schools [Internet], 2024 [cited 2026 March 30]. Available from: https:\/\/aafa.org\/advocacy\/key-issues\/access-to-medications\/albuterol-in-schools\/"},{"key":"1282_CR18","unstructured":"Centers for Disease Control and Prevention. Most Recent National Asthma Data: National Center for Environmental Health [Internet]. 2021 [cited 2026 March 30]. Available from: https:\/\/www.cdc.gov\/asthma\/most_recent_national_asthma_data.htm"},{"issue":"2","key":"1282_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jaci.2023.10.025","volume":"153","author":"TT Perry","year":"2024","unstructured":"Perry TT, Grant TL, Dantzer JA, Udemgba C, Jefferson AA. Impact of socioeconomic factors on allergic diseases. J Allergy Clin Immunol. 2024;153(2):368\u201377. https:\/\/doi.org\/10.1016\/j.jaci.2023.10.025.","journal-title":"J Allergy Clin Immunol"},{"key":"1282_CR20","unstructured":"American Lung Association. Single Maintenance and Reliever Therapy (SMART) Implementation in State Medicaid Programs [Internet] [cited 2026 March 30]. Available from: https:\/\/www.lung.org\/getmedia\/f6df836a-70d8-4ceb-afde-671d8ff6cd59\/ALA-SMART-Issue-Brief.pdf#:~:text=As%20of%20April%202023%2C%2045%20states%20covered,patients%20from%20using%20S"},{"key":"1282_CR21","unstructured":"Michigan Health & Human Services. How Michigan Medicaid can help your patients with asthma [Internet]. 2025 [cited 2026 March 30]. Available from: https:\/\/www.michigan.gov\/mdhhs\/-\/media\/Project\/Websites\/mdhhs\/Keeping-Michigan-Healthy\/Chronic-Disease\/Diabetes-and-other\/Provider_Medicaid-Fact-Sheet-2025.pdf"},{"key":"1282_CR22","unstructured":"Virginia Department of Medical Assistance Services. Virginia medicaid preferred drug list \/ Common core formulary and new drug utilization review board approved drug service authorizations [Internet]. 2024 [cited 2026 March 30]. Available from: https:\/\/vamedicaid.dmas.virginia.gov\/bulletin\/virginia-medicaid-preferred-drug-list-common-core-formulary-and-new-drug-utilization"},{"key":"1282_CR23","doi-asserted-by":"publisher","unstructured":"Greimann E, Lin CH, Freigeh G, Nelson B, Wettenstein R, Carpenter L et al. Treatment for mild asthma: what matters to providers. Ann Allergy Asthma Immunol. 2026; S1081-1206(26)00096\u2009\u2013\u20097. https:\/\/doi.org\/10.1016\/j.anai.2026.03.001","DOI":"10.1016\/j.anai.2026.03.001"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01282-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-026-01282-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01282-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:12:17Z","timestamp":1781334737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-026-01282-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1007\/s11882-026-01282-5","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}